Impact of medication and psychological behaviour assessment by community pharmacists in type 2 diabetes mellitus patients after hospital stay
- PMID: 25352870
- PMCID: PMC4209623
- DOI: 10.4314/ahs.v14i3.7
Impact of medication and psychological behaviour assessment by community pharmacists in type 2 diabetes mellitus patients after hospital stay
Abstract
Background: Drug related problem (DRPs) is a key factor which will affect the outcome of therapy and safety.
Objective: To assess the DRPs in type 2 diabetes mellitus (T2DM) patients and psychological aspects of patients by community pharmacists to observe the rate of DRP.
Methods: Prospective randomized controlled intervention study involved T2DM patients and conducted in two community pharmacies at Kanpur from January 2012 to December 2012. The assessment of DRPs was based on the PCNE. Changes in glycosylated hemoglobin (HBA1c), low density lipoproteins (LDL), blood pressure(BP), foot examinations, changes medical and medication utilization were studied. Using as control group, received usual care, and interventional group provided, intervened with use of the standard treatment guidelines (STG). Researcher provided the knowledge to community pharmacists and patients. Baseline and interventional data were collected at 0,3,6,9 and 12 months.
Results: Over the 12 month study, participants' average HBA1C reduced from 8.9% at initial visit to 7.5%. During this time, the eye examination rate was raised from 31% to 48%, and the foot examination rate was raised from 35% to 50%.
Conclusion: The intervention of pharmacists showed little influence on any of the intermediate health outcomes in T2DM.
Keywords: Drug related problems; Medication review; PCNE classification; Psychological behavior; Type 2 Diabetes Mellitus.
References
-
- Carrera Boada CA, Martínez-Moreno JM. Pathophysiology of diabetes mellitus type 2: beyond the duo “insulin resistance-secretion deficit”. Nutr Hosp. 2013;28(Supl. 2):78–87. - PubMed
-
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321. - PubMed
-
- Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. On behalf of the ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the ICMR - INDIAB study. Diabetologia. 2011;54:3022–3027. - PubMed
-
- Dobesh Paul P. Managing hypertension in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2006;63(12):1140–1149. - PubMed
-
- Rashed AN, Neubert A, Tomlin S, Jackman J, Alhamdan H, AlShaikh A, Attar A, Aseeri M, Wilton L, Wong IC. Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. Eur J Clin Pharmacol. 2012;68(12):1657–1666. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical